Logo image of TMX

Terminix Global Holdings Inc (TMX) Stock Fundamental Analysis

USA - NYSE:TMX - US88087E1001 - Common Stock

37.87 USD
-0.19 (-0.5%)
Last: 10/11/2022, 8:04:00 PM
37.7 USD
-0.17 (-0.45%)
After Hours: 10/11/2022, 8:04:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to TMX. TMX was compared to 75 industry peers in the Diversified Consumer Services industry. TMX has a bad profitability rating. Also its financial health evaluation is rather negative. TMX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year TMX was profitable.
In the past year TMX had a positive cash flow from operations.
TMX Yearly Net Income VS EBIT VS OCF VS FCFTMX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 200M 400M

1.2 Ratios

Industry RankSector Rank
ROA 1.47%
ROE 2.71%
ROIC 4.91%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TMX Yearly ROA, ROE, ROICTMX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 10 20 30 40

1.3 Margins

TMX's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of TMX has declined.
Industry RankSector Rank
OM 11.7%
PM (TTM) 3.15%
GM N/A
OM growth 3Y-6.56%
OM growth 5Y-5.92%
PM growth 3Y-0.81%
PM growth 5Y-32.41%
GM growth 3YN/A
GM growth 5YN/A
TMX Yearly Profit, Operating, Gross MarginsTMX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 20 30 40

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TMX is destroying value.
The number of shares outstanding for TMX has been reduced compared to 1 year ago.
The debt/assets ratio for TMX is higher compared to a year ago.
TMX Yearly Shares OutstandingTMX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M
TMX Yearly Total Debt VS Total AssetsTMX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 1B 2B 3B 4B 5B

2.2 Solvency

TMX has an Altman-Z score of 2.34. This is not the best score and indicates that TMX is in the grey zone with still only limited risk for bankruptcy at the moment.
The Debt to FCF ratio of TMX is 3.69, which is a good value as it means it would take TMX, 3.69 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.35 indicates that TMX is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.69
Altman-Z 2.34
ROIC/WACC0.55
WACC8.94%
TMX Yearly LT Debt VS Equity VS FCFTMX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 1.28 indicates that TMX should not have too much problems paying its short term obligations.
A Quick Ratio of 1.20 indicates that TMX should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.2
TMX Yearly Current Assets VS Current LiabilitesTMX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

TMX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.84%, which is quite good.
Measured over the past years, TMX shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.99% on average per year.
Looking at the last year, TMX shows a small growth in Revenue. The Revenue has grown by 4.60% in the last year.
TMX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.72% yearly.
EPS 1Y (TTM)14.84%
EPS 3Y-12.09%
EPS 5Y-6.99%
EPS Q2Q%0%
Revenue 1Y (TTM)4.6%
Revenue growth 3Y2.48%
Revenue growth 5Y-5.72%
Sales Q2Q%4.46%

3.2 Future

Based on estimates for the next years, TMX will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.74% on average per year.
TMX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.89% yearly.
EPS Next Y4.41%
EPS Next 2Y6.42%
EPS Next 3Y8.18%
EPS Next 5Y8.74%
Revenue Next Year3.74%
Revenue Next 2Y3.68%
Revenue Next 3Y4.03%
Revenue Next 5Y3.89%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TMX Yearly Revenue VS EstimatesTMX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B 2.5B
TMX Yearly EPS VS EstimatesTMX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 25.76 indicates a quite expensive valuation of TMX.
The average S&P500 Price/Earnings ratio is at 27.02. TMX is around the same levels.
The Price/Forward Earnings ratio is 23.55, which indicates a rather expensive current valuation of TMX.
The average S&P500 Price/Forward Earnings ratio is at 22.57. TMX is around the same levels.
Industry RankSector Rank
PE 25.76
Fwd PE 23.55
TMX Price Earnings VS Forward Price EarningsTMX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF 19.02
EV/EBITDA 14.7
TMX Per share dataTMX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TMX does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)5.84
PEG (5Y)N/A
EPS Next 2Y6.42%
EPS Next 3Y8.18%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TMX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Terminix Global Holdings Inc

NYSE:TMX (10/11/2022, 8:04:00 PM)

After market: 37.7 -0.17 (-0.45%)

37.87

-0.19 (-0.5%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)08-05 2022-08-05/amc
Earnings (Next)11-01 2022-11-01/bmo
Inst Owners0%
Inst Owner Change0%
Ins Owners0.08%
Ins Owner Change0%
Market Cap4.60B
Analysts73.33
Price Target47.26 (24.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.29%
Min EPS beat(2)-3.16%
Max EPS beat(2)5.73%
EPS beat(4)2
Avg EPS beat(4)-0.01%
Min EPS beat(4)-9.32%
Max EPS beat(4)6.7%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-0.8%
Max Revenue beat(2)-0.35%
Revenue beat(4)0
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-1.27%
Max Revenue beat(4)-0.35%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 25.76
Fwd PE 23.55
P/S 2.2
P/FCF 19.02
P/OCF 17.44
P/B 1.89
P/tB N/A
EV/EBITDA 14.7
EPS(TTM)1.47
EY3.88%
EPS(NY)1.61
Fwd EY4.25%
FCF(TTM)1.99
FCFY5.26%
OCF(TTM)2.17
OCFY5.74%
SpS17.23
BVpS20.04
TBVpS-5.94
PEG (NY)5.84
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.47%
ROE 2.71%
ROCE N/A
ROIC 4.91%
ROICexc N/A
ROICexgc 24.69%
OM 11.7%
PM (TTM) 3.15%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y16.11%
ROICexcg growth 5Y15.84%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-6.56%
OM growth 5Y-5.92%
PM growth 3Y-0.81%
PM growth 5Y-32.41%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.69
Debt/EBITDA N/A
Cap/Depr 20%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 366.67%
Current Ratio 1.28
Quick Ratio 1.2
Altman-Z 2.34
F-Score5
WACC8.94%
ROIC/WACC0.55
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.84%
EPS 3Y-12.09%
EPS 5Y-6.99%
EPS Q2Q%0%
EPS Next Y4.41%
EPS Next 2Y6.42%
EPS Next 3Y8.18%
EPS Next 5Y8.74%
Revenue 1Y (TTM)4.6%
Revenue growth 3Y2.48%
Revenue growth 5Y-5.72%
Sales Q2Q%4.46%
Revenue Next Year3.74%
Revenue Next 2Y3.68%
Revenue Next 3Y4.03%
Revenue Next 5Y3.89%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-6.56%
FCF growth 3Y-10.74%
FCF growth 5Y-2.68%
OCF growth 1Y-7.69%
OCF growth 3Y-11.95%
OCF growth 5Y-4.6%